Peptide Comparison
Pal-AHK vs Pentapeptide-18
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Pal-AHK and Pentapeptide-18 share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Pentapeptide-18 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Pentapeptide-18's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Pal-AHK | Pentapeptide-18 | |
|---|---|---|
| Class | Cosmetic lipopeptide (hair) | Cosmetic peptide; enkephalin mimetic |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Palmitoyl-modified AHK for enhanced skin/scalp penetration; angiogenic signaling | Enkephalin mimetic; modulates SNAP-25 at muscle-neuron interface (topical) |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 0.1-1% | Topical 2-10% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 2 indexed | 11 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Pal-AHK or Pentapeptide-18?
Pal-AHK and Pentapeptide-18 share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Pentapeptide-18 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Pentapeptide-18's evidence base is currently denser.
What is the difference between Pal-AHK and Pentapeptide-18?
Pal-AHK is classed as Cosmetic lipopeptide (hair); Pentapeptide-18 is classed as Cosmetic peptide; enkephalin mimetic. Reported mechanism: Pal-AHK, Palmitoyl-modified AHK for enhanced skin/scalp penetration; angiogenic signaling; Pentapeptide-18, Enkephalin mimetic; modulates SNAP-25 at muscle-neuron interface (topical). Reported half-life: Pal-AHK, Topical; Pentapeptide-18, Topical. Routes in published studies: Pal-AHK, Topical; Pentapeptide-18, Topical.
Which has stronger evidence, Pal-AHK or Pentapeptide-18?
Pal-AHK and Pentapeptide-18 sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Pal-AHK is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 2 indexed studies. Pentapeptide-18 is graded Cosmetic Clinical Studies, with 3 cited sources on its reference page and 11 indexed studies.
Which is more accessible, Pal-AHK or Pentapeptide-18?
Neither Pal-AHK nor Pentapeptide-18 is an FDA-approved drug. Catalog status: Pal-AHK, Cosmetic; Pentapeptide-18, Cosmetic.
Are Pal-AHK and Pentapeptide-18 ever combined?
Pal-AHK and Pentapeptide-18 appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…